| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/06/2000 | WO2000000238A1 Topoisomerase inhibitors for prevention of restenosis |
| 01/06/2000 | WO2000000211A2 Hydrocolloids obtained from portulaca oleracea and the use thereof |
| 01/06/2000 | WO2000000205A1 Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury |
| 01/06/2000 | WO2000000197A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 01/06/2000 | WO1999058505A3 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 01/06/2000 | CA2336625A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | CA2336162A1 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 01/06/2000 | CA2335842A1 Topoisomerase inhibitors for prevention of restenosis |
| 01/06/2000 | CA2335245A1 Hydrazine derivatives |
| 01/06/2000 | CA2332969A1 Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury |
| 01/06/2000 | CA2331386A1 Human signal peptide-containing proteins |
| 01/06/2000 | CA2330565A1 Growth factor modulators |
| 01/06/2000 | CA2327888A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 01/05/2000 | EP0969091A2 Leptin receptor gene-related protein |
| 01/05/2000 | EP0968715A1 Loratadine for use as an antiarrhymthmic |
| 01/05/2000 | EP0968713A1 Plasters containing isosorbide nitrate |
| 01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 01/05/2000 | EP0968286A1 Growth factor receptor binding protein |
| 01/05/2000 | EP0968230A1 Oxidized fragments of apolipoprotein b and their use |
| 01/05/2000 | EP0968210A1 Method of making arylamino triazolopyridines |
| 01/05/2000 | EP0968206A1 N-heterocyclic derivatives as nos inhibitors |
| 01/05/2000 | EP0968162A1 5-hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia |
| 01/05/2000 | EP0967986A2 USE OF HUMAN alpha 1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION |
| 01/05/2000 | EP0666856B1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 01/05/2000 | EP0610445B1 Use of compositions comprising a bactericidal/permeability increasing protein and a lipid carrier |
| 01/05/2000 | EP0427765B1 Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs |
| 01/05/2000 | DE19915954A1 Cyclooxygenaseinhibitor Cyclooxygenase |
| 01/05/2000 | CN1240450A Thienopyrimidine with phosphodiesterase V inhibiting effect |
| 01/05/2000 | CN1240445A Preparation of [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-chloro-2-thienyl)methyl] propyl] amino]-3H-imidazo [4,5-b] pyridin-3-y1]-n-ethyl-2 |
| 01/05/2000 | CN1240438A Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them |
| 01/05/2000 | CN1240424A Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 01/05/2000 | CN1240419A Aromatic amine derivatives having NOS inhibitory effect |
| 01/05/2000 | CN1240359A Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
| 01/05/2000 | CN1048014C Substituted pyrroles compound and preparational process, medicinal compositions and use |
| 01/04/2000 | US6011068 Carbocyclic-alkyl secondary amines |
| 01/04/2000 | US6011063 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/04/2000 | US6011059 Acyl guanidine sodium/proton exchange inhibitors and method |
| 01/04/2000 | US6011057 Methods for inhibiting uterine fibroid disease |
| 01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
| 01/04/2000 | US6011040 Use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine |
| 01/04/2000 | US6011035 Libraries of these compounds can also be used to identify antagonists for other targets. compounds containing benzhydril and 6-membered heterocyclic moieties |
| 01/04/2000 | US6011032 Heterocyclic compounds for treating myocardial ischemia |
| 01/04/2000 | US6011028 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 01/04/2000 | US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/04/2000 | US6011019 Vasoactive effects and free radical generation by β-amyloid peptides |
| 01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
| 01/04/2000 | US6010873 Modified complement system regulators |
| 01/04/2000 | US6010845 Leukocyte adhesion assay |
| 01/04/2000 | US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
| 01/01/2000 | CA2276984A1 Cyclooxygenase inhibitor |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067363A1 Ependymal neural stem cells and method for their isolation |
| 12/29/1999 | WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 12/29/1999 | WO1999067274A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 12/29/1999 | WO1999067262A1 Adenosine derivatives |
| 12/29/1999 | WO1999067261A1 NOVEL COMPOUNDS DERIVED FROM α-D-XYLOSE, PREPARATION METHOD AND THERAPEUTIC USE |
| 12/29/1999 | WO1999067258A1 Arylsulfonanilide phosphates |
| 12/29/1999 | WO1999067244A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 12/29/1999 | WO1999067236A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 12/29/1999 | WO1999067231A1 Nitrate salts of antihypertensive medicines |
| 12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 12/29/1999 | WO1999067207A1 Naphthalenesulfonamide derivatives and drugs containing the same |
| 12/29/1999 | WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | WO1999066943A1 Dietary supplement for supporting cerebrovascular tone |
| 12/29/1999 | WO1999066932A1 New use of a pyridazinone derivative |
| 12/29/1999 | WO1999066930A1 Compositions and methods for treating elevated blood cholesterol |
| 12/29/1999 | WO1999066929A1 Compositions and methods for treating elevated blood cholesterol |
| 12/29/1999 | WO1999066924A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
| 12/29/1999 | WO1999066918A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 12/29/1999 | WO1999066912A2 Method of treating pulmonary hypertension |
| 12/29/1999 | WO1999055305A3 Controlled release peroral compositions of levosimendan |
| 12/29/1999 | WO1999054315A3 Triazolones with a neuroprotective action |
| 12/29/1999 | WO1999053910A3 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 12/29/1999 | WO1999051626A3 Template associated npy y2-receptor agonists |
| 12/29/1999 | EP0967221A1 Process for preparing pharmacologically acceptable salts of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl amino acids |
| 12/29/1999 | EP0966965A1 Methods for reducing levels of homocysteine and C-reactive protein |
| 12/29/1999 | EP0966473A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 12/29/1999 | EP0966470A1 Dioxino derivatives and their use as therapeutic agents |
| 12/29/1999 | EP0966465A1 Inhibitors of impdh enzyme |
| 12/29/1999 | EP0966462A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| 12/29/1999 | EP0966460A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| 12/29/1999 | EP0966454A1 Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 12/29/1999 | EP0966447A1 Small molecules useful in the treatment of inflammatory disease |
| 12/29/1999 | EP0966446A1 Bicyclic inhibitors of protein farnesyl transferase |
| 12/29/1999 | EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 12/29/1999 | EP0966424A1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 12/29/1999 | EP0966423A1 Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent |
| 12/29/1999 | EP0966304A1 Site-specific drug delivery |
| 12/29/1999 | EP0966283A2 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 12/29/1999 | EP0966282A1 Use of angiotensin ii antagonists to treat symptomatic heart failure |
| 12/29/1999 | EP0966274A2 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase |
| 12/29/1999 | EP0966227A1 Composition containing a radioactive component for treatment of vessel wall |
| 12/29/1999 | EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 12/29/1999 | EP0677514B1 Cyclopropyl derivatives, preparation method thereof and applications |
| 12/29/1999 | EP0625048B1 Synthesis of human procollagens and collagens in recombinant dna systems |
| 12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 12/29/1999 | EP0612314B1 2-pyrazinylethylamine derivatives and their use as pharmaceuticals |